Status:

COMPLETED

Effects of Caffeine on Sleep-wake Regulation in Teenagers

Lead Sponsor:

Carolin Reichert

Collaborating Sponsors:

Swiss National Science Foundation

Pontificia Universidad Catolica de Chile

Conditions:

Adolescence

Caffeine

Eligibility:

MALE

14-17 years

Phase:

NA

Brief Summary

The aim is to quantify the effects of one dose of caffeine (compared to placebo) on sleep and wakefulness in adolescents.

Eligibility Criteria

Inclusion

  • Self-reported habitual caffeine consumption: min. 80 mg per month until max 300 mg per week as estimated from mean caffeine content per serving of caffeine containing beverages and food
  • Body-Mass-Index: 16.2-25.4
  • Informed Consent as documented by signature of participant
  • Informed Consent as documented by signature of legal representative

Exclusion

  • Previous enrollment into the current study
  • Investigators' family members, employees or other dependent persons
  • Left-handedness
  • No normal current health as based on questionnaires, screenings of urine, and examination by the physician in charge
  • Drug use: Volunteers must be drug-free for the entire duration of the study, with no history of drug or alcohol dependency.
  • Participation in other clinical trials \<3 months prior to study begin
  • Shift work \<3 months prior to study begin
  • Transmeridian travel (\>2 time zones) \<1 month prior to study begin
  • Extreme Chronotype (Munich Chronotype Questionnaire \[17\], MCTQ \<2 or \>7)
  • Short or long sleep duration: subjective sleep duration during schooldays not between 6-10 h (based on MCTQ)
  • Inability to follow procedures
  • Insufficient knowledge of project language (German)
  • Circumstances endangering MRI safety
  • Non-compliance with sleep/wake times during ambulatory part (deviation of more than ±1.5 hour from scheduled times)

Key Trial Info

Start Date :

April 13 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 15 2018

Estimated Enrollment :

18 Patients enrolled

Trial Details

Trial ID

NCT04321785

Start Date

April 13 2018

End Date

December 15 2018

Last Update

March 26 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Centre for Chronobiology

Basel, Switzerland